Human leumorphin is a potent, kappa opioid receptor agonistSUDA, M; NAKAO, K; YOSHIMASA, T et al.Neuroscience letters. 1984, Vol 50, Num 1-3, pp 49-52, issn 0304-3940Article

[³H] U-69593 labels a subtype of Kappa opiate receptor with characteristics different from that labeled by [³H] ethylketocyclazocineNOCK, B; ATUL RAJPARA; O'CONNOR, L. H et al.Life sciences (1973). 1988, Vol 42, Num 23, pp 2403-2412, issn 0024-3205Article

Resolution in the receptor binding of putative μ and κ opiatesMEDZIHRADSKY, F; DAHLSTROM, P. J; WOODS, J. H et al.Life sciences (1973). 1984, Vol 34, Num 22, pp 2129-2138, issn 0024-3205Article

Characterization of a K-agonist-like antinociceptive action of tifluadomUPTON, N; GONZALEZ, J. P; SEWELL, R. D. E et al.Neuropharmacology. 1983, Vol 22, Num 10, pp 1241-1242, issn 0028-3908Article

Functional coupling between DHP-sensitive calcium channels and kappa-opioid receptorsBARRO, M; RUIZ, F; HURLE, M. A et al.Regulatory peptides. 1994, pp S19-S20, issn 0167-0115, SUP1Conference Paper

Kappa agonists and vasopressin secretionHAMON, G; JOUQUEY, S.Hormone research. 1990, Vol 34, Num 3-4, pp 129-132, issn 0301-0163, 4 p.Conference Paper

Interaction with lectin of kappa opioid binding sites solubilized from human placentaVALETTE, A; ROUGE, P; COULAIS, E et al.Life sciences (1973). 1987, Vol 40, Num 6, pp 535-540, issn 0024-3205Article

Mu- and kappa-opiate agonists modulate ingestive behaviors in the slug, Limax maximusKAVALIERS, M; RANGELEY, R. W; HIRST, M et al.Pharmacology, biochemistry and behavior. 1986, Vol 24, Num 3, pp 561-566, issn 0091-3057Article

Blockade of U50,488H analgesia by antisense oligodeoxynucleotides to a κ-opioid receptorCHIH-CHENG CHIEN; BROWN, G; YING-XIAN PAN et al.European journal of pharmacology. 1994, Vol 253, Num 3, pp R7-R8, issn 0014-2999Article

Effect of sodium ion on the affinity of naloxone for the kappa opioid receptorCHENEY, B. V; LAHTI, R. A.Life sciences (1973). 1987, Vol 40, Num 11, pp 1071-1074, issn 0024-3205Article

Endorphins and food intake: Kappa opioid receptor agonists and hyperphagiaCOOPER, S. J; JACKSON, A; KIRKHAM, T. C et al.Pharmacology, biochemistry and behavior. 1985, Vol 23, Num 5, pp 889-901, issn 0091-3057Article

Molecular biology of kappa and delta opioid receptorsREISINE, T; KONG, H; YASUDA, K et al.Regulatory peptides. 1994, pp S5-S6, issn 0167-0115, SUP1Conference Paper

The kappa-opioid receptor from human placenta: hydrodynamic characteristics and evidence for its association with a G proteinPORTHE, G; FRANCES, B; VERRIER, B et al.Life sciences (1973). 1988, Vol 43, Num 6, pp 559-567, issn 0024-3205Article

Bremazocine-induced urination in rats of different sizesLEANDER, J. D.Research communications in chemical pathology and pharmacology. 1987, Vol 57, Num 1, pp 141-144, issn 0034-5164Article

Binding characteristics of kappa opioids in rat brain. A comparison of in vitro binding paradigmsWEYHENMEYER, J. A; MACK, K. J.Neuropharmacology. 1985, Vol 24, Num 2, pp 111-115, issn 0028-3908Article

Release of dynorphin-like immunoreactivity from rat anterior pituitary gland in vitroKNEPEL, W; SCHWANINGER, M.Naunyn-Schmiedeberg's archives of pharmacology. 1985, Vol 329, Num 1, pp 94-96, issn 0028-1298Article

Self-administration of ketocyclazocine and ethylketocyclazocine by the ratYOUNG, G. A; KHAZAN, N.Pharmacology, biochemistry and behavior. 1983, Vol 19, Num 4, pp 711-713, issn 0091-3057Article

Phenylpiperidine opioid antagonists that promote weight loss in rats have high affinity for the κ_2B (enkephalin-sensitive) binding siteROTHMAN, R. B; HENG XU; CHAR, G. U et al.Peptides (New York, NY. 1980). 1993, Vol 14, Num 1, pp 17-20, issn 0196-9781Article

Opioids and hibernation. II: Effects of kappa opioid U69593 on induction of hibernation in summer-active ground squirrels by «hibernation induction trigger» (HIT)OELTGEN, P. R; WELBORN, J. R; NUCHOLS, P. A et al.Life sciences (1973). 1987, Vol 41, Num 18, pp 2115-2120, issn 0024-3205Article

[³H]ethylketocyclazocine binding to mouse brain membranes: evidence for a kappa opioid receptor typeGARZON, J; SANCHEZ-BLAZQUEZ, P; LEE, N. M et al.The Journal of pharmacology and experimental therapeutics. 1984, Vol 231, Num 1, pp 33-37, issn 0022-3565Article

Involvement of κ-opioid receptors in opioid dependence/withdrawal : studied using buthorphanolJAW, S. P; MAKIMURA, M; OH, K. W et al.European journal of pharmacology. 1994, Vol 257, Num 1-2, pp 153-160, issn 0014-2999Article

Naltrexone in vivo protects μ receptors from inactivation by β-funaltrexamine, but not κ receptors from inactivation by nor-binaltorphiminePARONIS, C. A; WADDELL, A. B; HOLTZMAN, S. G et al.Pharmacology, biochemistry and behavior. 1993, Vol 46, Num 4, pp 813-817, issn 0091-3057Article

Naloxone benzoylhydrazone, a k₃ opioid agonist, stimulates food intake in ratsKOCH, J. E; PASTERNAK, G. W; ARJUNE, D et al.Brain research. 1992, Vol 581, Num 2, pp 311-314, issn 0006-8993Article

Antoradiographic visualization of kappa opioid receptors with labelled dynorphins in guinea pig brainSLATER, P; CROSS, A. J; HEWITT, L et al.Journal of receptor research. 1989, Vol 9, Num 2, pp 171-180, issn 0197-5110, 10 p.Article

Opioid binding site in EL-4 thymoma cell lineFIORICA, E; SPECTOR, S.Life sciences (1973). 1988, Vol 42, Num 2, pp 199-206, issn 0024-3205Article